 Insulin Resistance
"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Descriptor ID |
D007333
|
| MeSH Number(s) |
C18.452.394.968.500 G07.690.320.617
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 | | 1994 | 2 | 1 | 3 | | 1995 | 3 | 2 | 5 | | 1996 | 1 | 3 | 4 | | 1997 | 4 | 2 | 6 | | 1998 | 2 | 1 | 3 | | 1999 | 3 | 1 | 4 | | 2000 | 9 | 3 | 12 | | 2001 | 4 | 0 | 4 | | 2002 | 3 | 6 | 9 | | 2003 | 3 | 5 | 8 | | 2004 | 2 | 6 | 8 | | 2005 | 5 | 10 | 15 | | 2006 | 8 | 7 | 15 | | 2007 | 8 | 4 | 12 | | 2008 | 4 | 7 | 11 | | 2009 | 8 | 6 | 14 | | 2010 | 2 | 6 | 8 | | 2011 | 7 | 4 | 11 | | 2012 | 9 | 8 | 17 | | 2013 | 7 | 11 | 18 | | 2014 | 6 | 10 | 16 | | 2015 | 4 | 9 | 13 | | 2016 | 5 | 6 | 11 | | 2017 | 2 | 7 | 9 | | 2018 | 5 | 7 | 12 | | 2019 | 5 | 6 | 11 | | 2020 | 3 | 3 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Prabhakar NR, Peng YJ, Nanduri J. Hypoxia-inducible factors and obstructive sleep apnea. J Clin Invest. 2020 10 01; 130(10):5042-5051.
-
Wang N, Shi XF, Khan SA, Wang B, Semenza GL, Prabhakar NR, Nanduri J. Hypoxia-inducible factor-1 mediates pancreatic ß-cell dysfunction by intermittent hypoxia. Am J Physiol Cell Physiol. 2020 11 01; 319(5):C922-C932.
-
Kim TH, Banini BA, Asumda FZ, Campbell NA, Hu C, Moser CD, Shire AM, Han S, Ma C, Krishnan A, Mounajjed T, White TA, Gores GJ, LeBrasseur NK, Charlton MR, Roberts LR. Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020 09 01; 319(3):G333-G344.
-
Rangaraj VR, Siddula A, Burgess HJ, Pannain S, Knutson KL. Association between Timing of Energy Intake and Insulin Sensitivity: A Cross-Sectional Study. Nutrients. 2020 Feb 16; 12(2).
-
Philipson LH. Harnessing heterogeneity in type 2 diabetes mellitus. Nat Rev Endocrinol. 2020 02; 16(2):79-80.
-
Dick BP, McMahan R, Knowles T, Becker L, Gharib SA, Vaisar T, Wietecha T, O'Brien KD, Bornfeldt KE, Chait A, Kim F. Hematopoietic Cell-Expressed Endothelial Nitric Oxide Protects the Liver From Insulin Resistance. Arterioscler Thromb Vasc Biol. 2020 03; 40(3):670-681.
-
Wei L, Surma M, Yang Y, Tersey S, Shi J. ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice. FASEB J. 2020 01; 34(1):474-493.
-
Nguyen AB, Imamura T, Besser S, Rodgers D, Chung B, Raikhelkar J, Kalantari S, Smith B, Sarswat N, LaBuhn C, Jeevanandam V, Kim G, Sayer G, Uriel N. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. J Am Heart Assoc. 2019 11 19; 8(22):e013278.
-
Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020 Jan; 82(1):161-201.
-
Araki K, Araki A, Honda D, Izumoto T, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Hara A, Ikumi K, Kawai K, Ishigaki S, Nakamichi Y, Tsunekawa S, Seino Y, Yamamoto A, Takayama Y, Hidaka S, Tominaga M, Ohara-Imaizumi M, Suzuki A, Ishiguro H, Enomoto A, Yoshida M, Arima H, Muramatsu SI, Sobue G, Katsuno M. TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets. J Clin Invest. 2019 07 29; 129(9):3578-3593.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|